ARDX
Ardelyx, Inc.
Nasdaq · usd
Ardelyx, Inc. (ARDX) trades at $2.99 (-2.29%) as of 7:56:24 PM EST on Nov 20, 2026, -6.56% over the past month. Market cap is $751.6M, with 7.5 days to cover in short interest.
Stock performance
How Ardelyx, Inc. (ARDX) stock has performed from one day to one year, with its 52-week range.
- 1D
- -2.29%
- 1W
- -3.24%
- 1M
- -6.56%
- YTD
- -48.71%
- 1Y
- -45.64%
- 52-wk range
- $2.80 – $8.40
Key statistics
Today's trading snapshot for ARDX: day range, open, previous close, volume and market cap.
- Day range
- $2.95 – $3.08
- Open
- $3.01
- Prev close
- $3.06
- Volume
- 6.2M
- Market cap
- $751.6M
- Shares out
- 251.37M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Ardelyx, Inc.: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 1.64
- P/B
- 4.69
- P/FCF
- —
- ROE
- -33.8%
- ROA
- -9.4%
- Debt/Equity
- 1.54
- Div yield
- 0.00%
As of Nov 19, 2026
8-K filings
Material corporate events Ardelyx, Inc. has disclosed to the SEC on Form 8-K.
- Investor presentationNov 3, 2026
On November 3, 2026, the Company will host a conference call to discuss its financial results for the quarter ended September 30, 2026. A copy of the earnings presentation that will be used during this conference call is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.
- Executive officer departureAug 17, 2026
On August 11, 2026, Eric Foster notified Ardelyx, Inc. (the "Company") of his decision to resign as Chief Commercial Officer of the Company, effective August 28, 2026. Mr. Foster resigned to pursue a new opportunity with a pre-commercial company, and his resignation is not a result of any disagreement with the Company.
- Investor presentationAug 6, 2026
On August 6, 2026, the Company will host a conference call to discuss its financial results for the quarter ended June 30, 2026. A copy of the earnings presentation that will be used during this conference call is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
- Credit facility drawJul 2, 2026
On June 29, 2026, Ardelyx, Inc. (the "Company") received $50.0 million of funding (the "Term F Loan") pursuant to the loan and security agreement entered into in February 2022 by and between the Company and SLR Investment Corp., as collateral agent (the "Agent") and the lenders listed in the agreement (collectively, the "Lenders"), as amended in August 2022, February 2023, October 2023, October 2024, June 2025 and April 2026 (collectively, the "Loan Agreement").
- Shareholder proposal outcomeJun 17, 2026
The Company's stockholders approved, on a non-binding, advisory basis, the Say-On-Pay proposal with 137,617,786 votes for and 9,413,395 votes against. The Company's stockholders also approved, on a non-binding, advisory basis, the frequency of a Say-On-Pay vote occurring every one (1) year with 141,539,889 votes for.
ARDX short interest
How heavily ARDX is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 7.5
- Short interest
- 29.21M
- Avg volume
- 3.88M
As of · reported to FINRA twice monthly.
ARDX news
The latest news and headlines about Ardelyx, Inc. (ARDX).
- Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor HarmnegativeGlobeNewswire Inc.· Nov 16, 2026
- ARDX DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - ARDXnegativeGlobeNewswire Inc.· Nov 15, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor HarmnegativeGlobeNewswire Inc.· Nov 12, 2026
- SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Kinross Gold Corporation (NYSE: KGC) — Investors Who Suffered Losses Are Encouraged to Contact the FirmnegativeGlobeNewswire Inc.· Nov 12, 2026
- DOCS DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCSnegativeGlobeNewswire Inc.· Nov 9, 2026
Frequently asked questions
What is the Ardelyx, Inc. (ARDX) stock price today?
Ardelyx, Inc. (ARDX) is trading at $2.99 (-2.29% on the day) as of 7:56:24 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Ardelyx, Inc.?
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that…
What is the short interest in ARDX?
As of Oct 30, 2026, ARDX has 29.21M shares short and 7.5 days to cover.
What exchange is ARDX listed on?
Ardelyx, Inc. (ARDX) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of ARDX with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ARDX analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.